CIK 0000711377 · Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 382367843
- Phone
- 5173729200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Moylan John Patrick Chief Accounting Officer | Grant or award · Common Stock (Right to Buy) | +47,336 | 47,336 | ||
| 2025-08-15 | Nassif Mikheal CEO | Grant or award | +184,162 | $5.43 | $1000K | 184,162 |
| 2025-08-15 | Nassif Mikheal CEO | Grant or award | +414,365 | $5.43 | $2.3M | 598,527 |
| 2025-08-15 | Nassif Mikheal CEO | Grant or award · Common Stock (Right to Buy) | +1,065,042 | 1,065,042 | ||
| 2025-08-15 | Nassif Mikheal CEO | Grant or award · Common Stock (Right to Buy) | +473,352 | 473,352 | ||
| 2025-06-02 | Wainer Andrea F Director | Grant or award | +6,090 | $5.69 | $35K | 6,090 |
| 2025-06-02 | Wainer Andrea F Director | Grant or award · Common Stock (Right to Buy) | +16,303 | 16,303 | ||
| 2025-06-02 | Naemura David H. Chief Financial Officer | Grant or award | +52,724 | $5.69 | $300K | 114,158 |
| 2025-06-02 | Naemura David H. Chief Financial Officer | Grant or award · Common Stock (Right to Buy) | +211,723 | 211,723 | ||
| 2025-06-02 | Rocklin Amy M Chief Legal Officer | Grant or award | +43,585 | $5.69 | $248K | 80,436 |
| 2025-06-02 | Rocklin Amy M Chief Legal Officer | Grant or award · Common Stock (Right to Buy) | +175,024 | 175,024 | ||
| 2025-06-02 | Moylan John Patrick Chief Accounting Officer | Grant or award | +26,362 | $5.69 | $150K | 36,362 |
| 2025-06-02 | Moylan John Patrick Chief Accounting Officer | Grant or award · Common Stock (Right to Buy) | +70,574 | 70,574 | ||
| 2025-05-12 | Gupta Aashima Director | Purchase | +16,000 | $6.25 | $100K | 21,917 |
| 2025-05-01 | Moylan John Patrick Chief Accounting Officer | Option exercise | +4,558 | $5.15 | $23K | 14,558 |
| 2025-05-01 | Moylan John Patrick Chief Accounting Officer | Shares withheld for taxes | −1,603 | $5.15 | $8K | 12,955 |
| 2025-05-01 | Moylan John Patrick Chief Accounting Officer | Option exercise · Restricted Stock Units | −4,558 | $5.15 | $23K | 9,116 |
| 2025-04-28 | ADENT JOHN EDWARD CEO | Option exercise | +2,112 | $5.16 | $11K | 271,276 |
| 2025-04-28 | ADENT JOHN EDWARD CEO | Option exercise · Restricted Stock Units | −2,112 | $5.16 | $11K | 4,224 |
| 2025-04-28 | Jones Douglas Edward Chief Operating Officer | Option exercise | +845 | $5.16 | $4K | 72,004 |
Page 10 of 11 · 210 trades